期刊文献+

甲状腺乳头状癌组织中 miR-21的表达与临床预后的关系 被引量:5

Expression of miR-21 in papillary thyroid carcinoma and correlations thereof with extrathyroidal invasion and prognosis
下载PDF
导出
摘要 目的:检测甲状腺乳头状癌(PTC)肿瘤组织miR-21的表达,探讨miR-21在PTC表达对患者预后的影响。方法采用实时荧光定量聚合酶链反应(RT- PCR)检测手术切除的68例PTC肿瘤组织及癌旁正常组织中miR-21表达情况,分析甲状腺癌组织中miR-21的表达与临床病理参数的关系以及对患者预后的影响。结果 PTC患者肿瘤组织中miR-21的表达水平显著高于癌旁正常组织(P 〈0.05),PTC肿瘤组织中miR-21的表达水平与肿瘤腺外侵润有关(P 〈0.05),PTC患者肿瘤组织中 miR-21表达水平高者,其术后的复发转移率高于低表达者(P 〈0.05)。结论 miR-21在PTC患者肿瘤组织中的表达明显升高,其表达水平与肿瘤腺外侵润、术后复发转移有关。 Objective To investigate the expression of miR-21 in papillary thyroid carcinoma (PTC) tissue and to explore the correlations of miR-21 with the invasion and prognosis of PTC. Methods Sixty-eight surgically resected thyroid samples, including tumor tissues and normal tissues adjacent to carcinoma, underwent reverse transcription polymerase chain reaction to detect the expression levels of miR-21 in the different thyroid tissues. The correlations of miR-21 expression with the clinicopathological features and prognosis were analyzed. Results The expression level of miR-21 in the PTC tissue was significantly higher than that in the normal tissue adjacent to carcinoma (P 〈0.05). The expression level of miR-21 had a correlation with extrathyroidal invasion (P 〈0.05). The recurrent/metastatic rate of the patients with a higher miR-21 expression in tumor tissue was significantly higher than that of the patients with lower expression level (P 〈0.05). Conclusion The expression of miR-21 in PTC tissue is significantly higher than that in the normal tissue, and the up-regulated expression of miR-21 is correlated with the extrathyroidal invasion and recurrence/metastasis.
出处 《中国急救复苏与灾害医学杂志》 2015年第3期247-249,共3页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 甲状腺乳头状癌 MIR-21 预后 Papillary thyroid carcinoma Prognosis
  • 相关文献

参考文献3

二级参考文献38

  • 1刘东海,张乐鸣,张顺,毛联钢,冯伟云.乳腺癌患者c-erBb-2基因荧光定量PCR方法的研究[J].中国病理生理杂志,2006,22(2):380-383. 被引量:1
  • 2Ambros V.MicroRNA pathways in flies and worms:growth,death,fat,stress,and timing[J].Cell,2003,113(6):673-676.
  • 3Iorio MV,Ferracin M,Liu CG,et al.MicroRNA gene expression deregulation in human breast cancer[J].Cancer Res,2005,65(16):7065-7070.
  • 4Chan JA,Krichevsky AM,Kosik KS.MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells[J].Cancer Res,2005,65(14):6029-6033.
  • 5Yanaihara N,Caplen N,Bowman E,et al.Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J].Cancer Cell,2006,9(3):189-198.
  • 6Singletary SE,Allred C,Ashley P,et al.Staging system for breast cancer:revisions for the 6th edition of the AJCC Cancer Staging Manual[J].Surg Clin North Am,2003,83(4):803-819.
  • 7Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method[J].Methods,2001,25(4):402-408.
  • 8Gramantieri L,Ferracin M,Fornari F,et al.Cyclin G1 is a target of miR-122a,a microRNA frequently down-regulated in human hepatocellular carcinoma[J].Cancer Res,2007,67(13):6092-6099.
  • 9Rhodes A,Jasani B,Anderson E,et al.Evaluation of HER-2/neu immunohistochemical assay sensitivity and scoring on formalin-fixed and paraffin-processed cell lines and breast tumors:a comparative study involving results from laboratories in 21 countries[J].Am J Clin Pathol,2002,118(3):408-417.
  • 10Si ML,Zhu S,Wu H,et al.miR-21-mediated tumor growth[J].Oncogene,2007,26(19):2799-2803.

共引文献28

同被引文献33

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部